Zazove Associates Portfolio holdings
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BKEP
Blueknight Energy Partners L.P.
BKEP
|
+$10.9M |
| 2 |
BKEPP
Blueknight Energy Partners L.P., L.L.C. Series A Preferred Units
BKEPP
|
+$4.12M |
| 3 |
SMM
Salient Midstream & MLP Fund
SMM
|
+$1.65M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$1.19M |
| 5 |
BRC Inc
BRCC
|
+$686K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 1.99% |
| 2 | Real Estate | 0.92% |
| 3 | Materials | 0.79% |
| 4 | Energy | 0.54% |
| 5 | Healthcare | 0.46% |
Similar funds
Zazove Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Zazove Associates held 188 positions worth $1.11B, up 5% from $1.05B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Zazove Associates withdrew a net $863M in Q3 2022, closing 21 positions and reducing 5 holdings. Its most notable exit was Blueknight Energy Partners L.P., an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 2% of assets, down from 2% a quarter earlier, followed by Real Estate and Materials.
Against the trend, Zazove Associates opened a new position in PetIQ, Inc. Class A Common Stock worth $3.66M.
- Zazove Associates's largest Q3 2022 buy was PetIQ, Inc. Class A Common Stock: 530,000 shares worth $3.66M.
- Zazove Associates added most to Executive Network Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q3 2022, an estimated $1.34M increase.
- Zazove Associates's biggest Q3 2022 reduction was BRC Inc, cutting an estimated $686K.
- Zazove Associates fully exited Blueknight Energy Partners L.P. in Q3 2022, selling an estimated $10.9M.
- Zazove Associates's ten largest holdings make up 38% of its $1.11B portfolio in Q3 2022.
- Zazove Associates opened 6 new positions and closed 21 in Q3 2022.
- Zazove Associates's portfolio value rose 5% quarter-over-quarter to $1.11B.
Based on Zazove Associates's 13F filing for Q3 2022, filed 24 Oct 2022.